Sedat Şen

1.4k total citations
18 papers, 150 citations indexed

About

Sedat Şen is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Sedat Şen has authored 18 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in Sedat Şen's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Sedat Şen is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Sedat Şen collaborates with scholars based in Türkiye, Antigua and Barbuda and Switzerland. Sedat Şen's co-authors include Murat Terzi, Cavit Boz, Y. Sarac, Serkan Özakbaş, Gamze Altun, Kıymet Kübra Yurt, Süleyman Kaplan, Barış Genç, Canan Yücesan and Eşref Akıl and has published in prestigious journals such as Nephrology Dialysis Transplantation, Multiple Sclerosis Journal and International Journal of Clinical Practice.

In The Last Decade

Sedat Şen

15 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sedat Şen Türkiye 7 75 41 24 23 18 18 150
Maria Edite Rio Portugal 5 47 0.6× 17 0.4× 14 0.6× 5 0.2× 20 1.1× 8 167
Sebastiano Bucello Italy 6 72 1.0× 37 0.9× 20 0.8× 24 1.0× 3 0.2× 8 150
Sverre Uhlving Norway 6 39 0.5× 9 0.2× 18 0.8× 11 0.5× 24 1.3× 7 399
Ioan Buraga Romania 5 27 0.4× 40 1.0× 15 0.6× 13 0.6× 18 1.0× 17 96
Susana Otero-Romero Spain 2 60 0.8× 58 1.4× 19 0.8× 3 0.1× 8 0.4× 4 117
Jeff Jacobson United States 4 29 0.4× 129 3.1× 17 0.7× 5 0.2× 50 2.8× 5 239
D. Rodríguez Argentina 5 72 1.0× 68 1.7× 6 0.3× 45 2.0× 3 0.2× 6 159
Hrvoje Budinčević Croatia 8 10 0.1× 49 1.2× 10 0.4× 10 0.4× 61 3.4× 41 183
Nerina Mascoli Italy 8 226 3.0× 119 2.9× 12 0.5× 6 0.3× 27 1.5× 11 293
Yuhan Qiu China 8 132 1.8× 91 2.2× 21 0.9× 7 0.3× 8 0.4× 17 221

Countries citing papers authored by Sedat Şen

Since Specialization
Citations

This map shows the geographic impact of Sedat Şen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sedat Şen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sedat Şen more than expected).

Fields of papers citing papers by Sedat Şen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sedat Şen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sedat Şen. The network helps show where Sedat Şen may publish in the future.

Co-authorship network of co-authors of Sedat Şen

This figure shows the co-authorship network connecting the top 25 collaborators of Sedat Şen. A scholar is included among the top collaborators of Sedat Şen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sedat Şen. Sedat Şen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Beckmann, Yeşim, et al.. (2025). Kappa-free light chain as a practical alternative to oligoclonal bands in the diagnosis of multiple sclerosis. Multiple Sclerosis and Related Disorders. 97. 106377–106377. 1 indexed citations
3.
Genç, Barış, Sedat Şen, Kerim Aslan, & Lütfi İncesu. (2023). Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis. Neuroradiology. 65(5). 899–905. 5 indexed citations
4.
Genç, Barış, Kerim Aslan, Sedat Şen, & Lütfi İncesu. (2023). Cortical morphological changes in multiple sclerosis patients: a study of cortical thickness, sulcal depth, and local gyrification index. Neuroradiology. 65(9). 1405–1413. 3 indexed citations
5.
Şen, Sedat, Murat Terzi, Serkan Özakbaş, et al.. (2023). Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment. Multiple Sclerosis and Related Disorders. 79. 104949–104949. 4 indexed citations
6.
Gümüş, Haluk, Tuncay Gündüz, Serkan Demir, et al.. (2022). The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in Turkey. Nöro Psikiyatri Arşivi. 59(3). 226–231.
7.
Demir, Serkan, Melih Tütüncü, Haluk Gümüş, et al.. (2021). A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey. Multiple Sclerosis and Related Disorders. 52. 103005–103005. 2 indexed citations
8.
Tütüncü, Melih, Tuncay Gündüz, Haluk Gümüş, et al.. (2021). The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey. International Journal of Clinical Practice. 75(7). e14158–e14158. 6 indexed citations
9.
Şen, Sedat, et al.. (2020). Screening of dysphagia by DYMUS (Dysphagia in multiple sclerosis) and SWALQoL (Swallowing quality of life) surveys in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 45. 102397–102397. 4 indexed citations
10.
Sevim, Serhan, Meltem Demirkıran, Murat Terzi, et al.. (2020). ‘Is RLS a harbinger and consequence of MS?: Striking results of the ‘RELOMS-T’ study’. Multiple Sclerosis and Related Disorders. 42. 102055–102055. 5 indexed citations
11.
Boz, Cavit, et al.. (2020). Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone. Clinical Neurology and Neurosurgery. 197. 106118–106118. 13 indexed citations
12.
Şen, Sedat. (2018). NEUROSTATUS AND EDSS CALCULATION WITH CASES. Nöro Psikiyatri Arşivi. 55(Suppl 1). S80–S83. 22 indexed citations
13.
Özakbaş, Serkan, Recai Türkoğlu, Yusuf Tamam, et al.. (2018). Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial. Multiple Sclerosis and Related Disorders. 22. 70–76. 28 indexed citations
14.
Terzi, Murat, et al.. (2017). The use of non-steroidal anti-inflammatory drugs in neurological diseases. Journal of Chemical Neuroanatomy. 87. 12–24. 22 indexed citations
15.
Boz, Cavit, et al.. (2017). Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis. Multiple Sclerosis Journal. 24(9). 1205–1211. 20 indexed citations
16.
Yüksel, Esra Pancar, et al.. (2013). Phenobarbital-induced pellagra resulted in death. Cutaneous and Ocular Toxicology. 33(1). 76–78. 2 indexed citations
17.
Şen, Sedat & Murat Terzi. (2013). Paraneoplastic neurologic disorders. Journal of Experimental and Clinical Medicine. 30(3). 209–213.
18.
Akpolat, Tekin, Nurol Arık, Murat Günaydın, et al.. (1995). Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study. Nephrology Dialysis Transplantation. 10(4). 479–480. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026